Abstract
The purpose of the present study was to provide further information about the effects of gamma-hydroxybutyrate (GHB) on memory. Initially, the acute effects of gamma-butyrolactone (GBL, 75-200 mg/kg IP), 1,4-butanediol (1,4-BD, 100-300 mg/kg IP), and ethanol (1.0-3.0 g/kg, oral), as well as GHB (100-300 mg/kg IP), were examined in rats responding under a delayed-matching-to-position (DMTP) procedure with delays from 0 to 32 s. Acute administration of all four drugs reduced the number of trials completed and also reduced accuracy during delay trials, but not during trials without a delay. Some tolerance developed to the disruptive effects of GHB following exposure to 300 mg/kg/day for 29 consecutive days. These data indicate that GHB can disrupt working memory and speed of responding, and that tolerance can develop to these effects. Moreover, the acute effects of GHB under the DMTP procedure resemble those of its metabolic precursors, GBL and 1,4-BD, and of the prototypical CNS depressant drug, ethanol.
References
Jun 15, 1977·Life Sciences·O C Snead
Jan 1, 1990·Psychopharmacology·K F MeliaC L Ehlers
Sep 30, 1989·Lancet·L GallimbertiG L Gessa
Jul 1, 1988·Acta Psychiatrica Scandinavica·G CantonL Gallimberti
Oct 1, 1987·Behavioural Brain Research·R K NakamuraA F Mirsky
Feb 1, 1971·British Journal of Anaesthesia·I G Grove-White, G R Kelman
Feb 6, 1995·European Journal of Pharmacology·G ColomboG L Gessa
Aug 1, 1993·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·L GallimbertiG L Gessa
Jan 1, 1997·Addiction·G P GallowayD E Smith
Jan 1, 1997·Journal of Toxicology. Clinical Toxicology·G Tunnicliff
Jun 19, 1998·Psychopharmacology·S P BaronG R Wenger
Jun 7, 2000·Behavioural Brain Research·J K RobinsonC J Han
Jul 6, 2000·Southern Medical Journal·R H SchwartzM A LeBeau
Sep 2, 2000·European Journal of Pharmacology·C J HanJ K Robinson
Apr 12, 2001·Drug and Alcohol Dependence·K L Nicholson, R L Balster
Oct 3, 2001·The American Journal on Addictions·K MiottoR Rawson
Sep 11, 2002·Journal of Substance Abuse Treatment·Thomas E FreeseCathy J Reback
Feb 28, 2003·The Journal of Pharmacology and Experimental Therapeutics·Lawrence P CarterCharles P France
Jun 6, 2003·Forensic Science International : Synergy·C Lora-TamayoE Molina
Jul 2, 2003·The Journal of Pharmacy and Pharmacology·Diederik K Van SassenbroeckWalter A Buylaert
Oct 4, 2003·Pharmacotherapy·David E Fuller, Carl S Hornfeldt
Apr 6, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·David E FullerTodd F Anderson
Apr 6, 2004·Psychopharmacology·T Escher, G Mittleman
Aug 10, 2004·Toxicological Reviews·Asim F Tarabar, Lewis S Nelson
Dec 8, 2004·Pharmacology, Biochemistry, and Behavior·Ratna Sircar, Ashim Basak
Jul 8, 2005·Psychopharmacology·Lisa E BakerAlan Poling
May 9, 2006·Behavioural Brain Research·Hazel L SloanStephen B Dunnett
Aug 2, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lawrence P CarterRoland R Griffiths
Aug 21, 2007·Journal of Psychoactive Drugs·Judith C BarkerJo E Dyer
Oct 2, 2007·Pharmacology, Biochemistry, and Behavior·Sean LarawayAlan Poling